Stryker share price today
(NASDAQ: SYK)

Name: Stryker Share Price Today (NASDAQ: SYK) - Stryker Stock Price Live Quote | INDmoney
Brand: INDmoney
Rating: 4.7 (371551 reviews)

Stryker share price is $393.5 & ₹34,033.81 as on 24 Jan 2025, 2.30 'hrs' IST

$393.5

▲

3.01

(0.77%)

Market is closed - opens 8 PM, 24 Jan 2025

View live Stryker share price in Dollar and Rupees. Guide to invest in Stryker stock from India, including Indian investor sentiment. Get details on Indian mutual funds investing in Stryker, along with analyst recommendations, forecasts, and comprehensive financials.

Stryker share price movements

Today's Low: $389.55
Today's High: $394.45
$393.50
1.0%
Downside
Day's Volatility :1.24%
Upside
0.24%
52 Weeks Low: $307.23
52 Weeks High: $398.20
$393.50
21.92%
Downside
52 Weeks Volatility :22.85%
Upside
1.18%

Stryker Returns

Period	Stryker Corporation	Sector (Health Care)	S&P500
3 Months	10.68%	-4.8%	4.8%
6 Months	17.73%	-5.1%	12.1%
1 Year	25.19%	2.5%	25.0%
3 Years	56.65%	10.2%	38.0%

Stryker Key Statistics

in dollars & INR

Previous Close	$390.49
Open	$391.12
Today's High	$394.45
Today's Low	$389.55
Market Capitalization	$150.9B
Today's Volume	$2.0M
52 Week High	$398.2
52 Week Low	$307.23
Revenue TTM	$22.0B
EBITDA	$5.7B
Earnings Per Share (EPS)	$9.32
PE Ratio	42.47
Dividend Yield	0.88%
Profit Margin	16.34%
Quarterly Earnings Growth YOY	0.2%
Return On Equity TTM	18.87%

How to invest in Stryker Stock (SYK) from India?

It is very easy for Indian residents to invest directly in Stryker from India. Indian investors can open a free US stocks account on the INDmoney app. You can find live prices of the Stryker stock in both Indian Rupees (INR) and US Dollars (USD). Search for Stryker or SYK on the INDmoney app and click on Buy or SIP. You can invest by choosing quantities of shares of Stryker or rupee/ dollar value or set up a fixed SIP amount to be invested every month or week.

For example: You can easily buy Rs.100 worth of Stryker shares which would translate to 0.002 fractional shares of Stryker as of today. Learn more about fractional investing.

Indians can now also easily transfer and add money to their US stocks account via the INDmoney app. Invest in US Stocks from India, including recognised companies like Stryker, in just a few clicks!

Returns in Stryker for Indian investors in Rupees

Investment Value

₹1,00,000

Stryker investment value today

Current value as on today

₹1,30,268

Returns

₹30,268

(+30.27%)

Returns from Stryker Stock

₹26,158 (+26.16%)

Dollar Returns

₹4,109 (+4.11%)

Indian investors sentiment towards Stryker

-6.12%

Period: Oct 25, 2024 to Jan 23, 2025. Change in 30 Days versus previous period

Investment in Stryker from India has reduced in the last 30 days as on Jan 24, 2025. -6.12% less purchase transactions for Stryker in the last 30 days versus the previous period.

37%

Period: Oct 25, 2024 to Jan 23, 2025. Change in 30 Days versus previous period

Search volume for Stryker on INDmoney from India has grown in the last 30 days as on Jan 24, 2025. 37% more investors are searching Stryker in the last 30 days versus the previous period.

Indian Mutual Funds that invest in Stryker

Name	Shares Held	Change in Shares	% of Assets
Motilal Oswal S&P 500 Index Fund Direct Growth	2960	25.13	0.24%
Edelweiss MSCI India Domestic & World Healthcare 45 Index Fund Direct Growth	518	0.00	1.01%

Global Institutional Holdings in Stryker

Vanguard Group Inc
8.51%
BlackRock Inc
7.25%
Greenleaf Trust
4.86%
State Street Corp
3.83%
T. Rowe Price Associates, Inc.
2.90%
JPMorgan Chase & Co
2.84%

Analyst Recommendation on Stryker

Buy

67%Buy

32%Hold

0%Sell

Based on 34 Wall street analysts offering stock ratings for Stryker(by analysts ranked 0 to 5 stars)

Based on 34 analyst

Current
1M Ago
3M Ago

Buy

Hold

Sell

Analyst Forecast on Stryker

What analysts predicted

Upside of 3.81%

Target:

$408.49

Current:

$393.50

Insights on Stryker

Price Movement
In the last 3 years, SYK stock has moved up by 55.0%
Increasing Revenue
Stryker Corporation has shown positive revenue growth over the last three quarters. Their revenue increased from $5.24 billion to $5.49 billion, reflecting an average increase of 2.3% per quarter.
Increasing Net Profit
Stryker Corporation has seen a positive trend in its net profit over the last three quarters. Specifically, the net profit increased from $788.0 million to $834.0 million, which reflects an average growth of 2.8% per quarter.
SYK vs BSX (1 yr)
In the last 1 year, Boston Scientific Corp. has given 67.4% return, outperforming this stock by 40.5%
SYK vs BSX (3 yr)
In the last 3 years, Boston Scientific Corp. has given 135.1% return, outperforming this stock by 80.1%
Price to Sales
Stryker Corporation's Price-to-Sales Ratio is 6.8, which means that investors are willing to pay $6.8 for every $1 of sales the company generates. In comparison, investors pay $9.4 for every $1 of sales for Boston Scientific Corp. This indicates that Stryker is viewed as a less expensive investment relative to its sales than Boston Scientific.

Stryker Financials in INR & Dollars

	FY18	Y/Y Change
Revenue	$13.6B	↑ 9.3%
Net Income	$3.6B	↑ 248.33%
Net Profit Margin	26.12%	↑ 17.92%

	FY19	Y/Y Change
Revenue	$14.9B	↑ 9.43%
Net Income	$2.1B	↓ 41.37%
Net Profit Margin	13.99%	↓ 12.13%

	FY20	Y/Y Change
Revenue	$14.4B	↓ 3.58%
Net Income	$1.6B	↓ 23.24%
Net Profit Margin	11.14%	↓ 2.85%

	FY21	Y/Y Change
Revenue	$17.1B	↑ 19.21%
Net Income	$2.0B	↑ 24.7%
Net Profit Margin	11.66%	↑ 0.52%

	FY22	Y/Y Change
Revenue	$18.4B	↑ 7.84%
Net Income	$2.4B	↑ 18.25%
Net Profit Margin	12.78%	↑ 1.12%

	FY23	Y/Y Change
Revenue	$20.5B	↑ 11.11%
Net Income	$3.2B	↑ 34.22%
Net Profit Margin	15.44%	↑ 2.66%

	Q2 FY23	Q/Q Change
Revenue	$5.0B	↑ 4.56%
Net Income	$738.0M	↑ 24.66%
Net Profit Margin	14.77%	↑ 2.38%

	Q3 FY23	Q/Q Change
Revenue	$4.9B	↓ 1.74%
Net Income	$692.0M	↓ 6.23%
Net Profit Margin	14.1%	↓ 0.67%

	Q4 FY23	Q/Q Change
Revenue	$5.8B	↑ 18.46%
Net Income	$1.1B	↑ 65.17%
Net Profit Margin	19.66%	↑ 5.56%

	Q1 FY24	Q/Q Change
Revenue	$5.2B	↓ 9.84%
Net Income	$788.0M	↓ 31.06%
Net Profit Margin	15.03%	↓ 4.63%

	Q2 FY24	Q/Q Change
Revenue	$5.4B	↑ 3.41%
Net Income	$825.0M	↑ 4.7%
Net Profit Margin	15.22%	↑ 0.19%

	Q3 FY24	Q/Q Change
Revenue	$5.5B	↑ 1.33%
Net Income	$834.0M	↑ 1.09%
Net Profit Margin	15.18%	↓ 0.04%

	FY18	Y/Y Change
Profit	$8.9B	↑ 9.36%

	FY19	Y/Y Change
Profit	$9.7B	↑ 8.48%

	FY20	Y/Y Change
Profit	$9.1B	↓ 6.59%

	FY21	Y/Y Change
Profit	$11.0B	↑ 21.1%

	FY22	Y/Y Change
Profit	$11.6B	↑ 5.56%

	FY23	Y/Y Change
Profit	$13.1B	↑ 13.12%

	Q2 FY23	Q/Q Change
Profit	$3.2B	↑ 5.47%

	Q3 FY23	Q/Q Change
Profit	$3.2B	↓ 0.72%

	Q4 FY23	Q/Q Change
Profit	$3.7B	↑ 17.26%

	Q1 FY24	Q/Q Change
Profit	$3.2B	↓ 14.02%

	Q2 FY24	Q/Q Change
Profit	$3.3B	↑ 4.4%

	Q3 FY24	Q/Q Change
Profit	$3.5B	↑ 5.81%

	FY18	Y/Y Change
Operating Cash Flow	$2.6B	↑ 67.42%
Investing Cash Flow	$-2.9B	↑ 77.12%
Financing Cash Flow	$1.3B	↓ 267.38%

	FY19	Y/Y Change
Operating Cash Flow	$2.2B	↓ 16.05%
Investing Cash Flow	$-1.5B	↓ 49.07%
Financing Cash Flow	$3.0M	↓ 99.77%

	FY20	Y/Y Change
Operating Cash Flow	$3.3B	↑ 49.57%
Investing Cash Flow	$-4.7B	↑ 223.09%
Financing Cash Flow	$-11.0M	↓ 466.67%

	FY21	Y/Y Change
Operating Cash Flow	$3.3B	↓ 0.43%
Investing Cash Flow	$-859.0M	↓ 81.73%
Financing Cash Flow	$-2.4B	↑ 21400.0%

	FY22	Y/Y Change
Operating Cash Flow	$2.6B	↓ 19.58%
Investing Cash Flow	$-2.9B	↑ 240.4%
Financing Cash Flow	$-749.0M	↓ 68.33%

	Q2 FY23	Q/Q Change
Operating Cash Flow	$688.0M	↑ 54.61%
Investing Cash Flow	$-533.0M	↑ 303.79%
Financing Cash Flow	$-405.0M	↓ 15.8%

	Q3 FY23	Q/Q Change
Operating Cash Flow	$1.1B	↑ 52.62%
Investing Cash Flow	$-810.0M	↑ 51.97%
Financing Cash Flow	$-422.0M	↑ 4.2%

Stryker Technicals Summary

Sell

Neutral

Buy

Stryker is currently in a favorable trading position ( BUY ) according to technical analysis indicators.

Stryker Vs Peers

Company Name	1 Month	6 Month	1 Year	3 Years	5 Years
Stryker Corporation	5.7%	17.73%	25.19%	56.65%	81.96%
Medtronic Plc	7.65%	11.61%	2.39%	-15.68%	-26.33%
Edwards Lifesciences Corp.	-9.06%	10.69%	-6.13%	-36.94%	-9.52%
Boston Scientific Corp.	9.69%	33.89%	64.9%	135.97%	135.19%
Abbott Laboratories	2.18%	11.92%	4.74%	-4.45%	31.47%

Company Name	P/E Ratio	P/B Ratio	PEG Ratio	EPS	ROE	ROA	Div Yield	BVPS
Stryker Corporation	42.47	42.47	2.68	12.06	0.19	0.07	0.01	52.86
Medtronic Plc	27.03	27.03	1.5	5.46	0.08	0.04	0.03	38.29
Edwards Lifesciences Corp.	26.66	26.66	6.43	2.55	0.19	0.11	NA	16.18
Boston Scientific Corp.	83.4	83.4	1.79	2.46	0.09	0.05	NA	14.05
Abbott Laboratories	34.45	34.45	2.2	4.67	0.15	0.06	0.02	22.94

Company Name	Analyst View	Market Cap	5 Years Return %	PE Ratio	Profit Margin
Stryker Corporation	Buy	$150.9B	81.96%	42.47	16.34%
Medtronic Plc	Buy	$113.3B	-26.33%	27.03	12.06%
Edwards Lifesciences Corp.	Buy	$40.7B	-9.52%	26.66	65.86%
Boston Scientific Corp.	Buy	$148.7B	135.19%	83.4	11.26%
Abbott Laboratories	Buy	$202.6B	31.47%	34.45	13.99%

Stryker Dividend announcements

Stryker Dividends December, 2024
In the quarter ending December,2024. Stryker has declared dividend of $0.84
Read More

About Stryker

Stryker Corporation operates as a medical technology company. The company operates through two segments, MedSurg and Neurotechnology, and Orthopaedics and Spine. The Orthopaedics and Spine segment provides implants for use in total joint replacements, such as hip, knee and shoulder, and trauma and extremities surgeries. This segment also offers spinal implant products comprising cervical and thoracolumbar systems that include fixation, minimally invasive and interbody systems used in spinal injury, complex spine and degenerative therapies. The MedSurg and Neurotechnology segment offers surgical equipment, and surgical navigation systems, endoscopic and communications systems, patient handling, emergency medical equipment and intensive care disposable products, reprocessed and remanufactured medical devices, clinical communication and workflow solutions, and other medical device products that are used in various medical specialties, as well as patient and caregiver safety technologies. This segment also provides neurosurgical, neurovascular and craniomaxillofacial implant products, which include products used for minimally invasive endovascular procedures; products for brain and open skull based surgical procedures; orthobiologic and biosurgery products, such as synthetic bone grafts and vertebral augmentation products; minimally invasive products for the treatment of acute ischemic and hemorrhagic stroke; and craniomaxillofacial implant products, including cranial, maxillofacial, and chest wall devices, as well as dural substitutes and sealants. The company sells its products to doctors, hospitals, and other healthcare facilities through company-owned subsidiaries and branches, as well as third-party dealers and distributors in approximately 75 countries. Stryker Corporation was founded in 1941 and is headquartered in Portage, Michigan.

Organization	Stryker
Employees	52000
CEO	Mr. Kevin A. Lobo
Industry	Health Technology

Management People of Stryker

Name	Title
Mr. Kevin A. Lobo	Chairman, CEO & President
Mr. Glenn S. Boehnlein CPA	VP & CFO
Mr. Viju S. Menon	Group President of Global Quality & Operations
Mr. J. Andrew Pierce	Group President of MedSurg & Neurotechnology
Mr. Spencer S. Stiles	Group President of Orthopaedics & Spine
Mr. William E. Berry Jr.	VP & Chief Accounting Officer
Mr. Robert C. Cohen	CTO and VP of Global R&D - Joint Replacement
Mr. Alan Douville	VP, Chief Information Officer & Chief Information Security Officer
Mr. Jason Beach	Vice President of Finance & Investor Relations
Mr. Robert S. Fletcher	VP & Chief Legal Officer

Important FAQs about investing in Stryker (SYK) from India :

What is Stryker share price today?

Stryker share price today stands at $393.50, Open: $391.12 ; Previous Close: $390.49 ; High: $394.45 ; Low: $389.55 ; 52 Week High: $398.20 ; 52 Week Low: $307.23. The stock opens at $391.12, after a previous close of $390.49. The stock reached a daily high of $394.45 and a low of $389.55, with a 52-week high of $398.20 and a 52-week low of $307.23.

Can Indians buy Stryker shares?

Yes, Indians can invest in the Stryker (SYK) from India.

With INDmoney, you can buy Stryker at 0 brokerage. The step-by-step process is as follows:

Open your zero cost US Stocks account and zero balance IND linked savings a/c (this can be done in less than 3 minutes)
Transfer funds to your US Stocks account using your IND linked savings a/c (It takes 24 hours excluding Saturday and Sunday). With INDmoney, you get the best INR USD exchange rates.
Once funds are transferred successfully, you can buy Stryker at zero transaction cost.

How can I buy Stryker shares from India?

It is very easy to buy Stryker from India. With INDmoney, you can open a US stocks account in less than 3 minutes. Transfer funds in 24 hours and buy stocks very easily - that too at 0 brokerage. All this is done at 0 account opening & management fee, 0 brokerages, and at the same time you get the best rupee-US dollar exchange rate.

Can Fractional shares of Stryker be purchased?

Yes, you can buy fractional shares of Stryker with INDmoney app.

What are the documents required to start investing in Stryker stocks?

To start investing in Stryker, You will need the following documents:

Proof of Identification (PAN, Aadhaar etc)
Proof of address (Aadhaar, Voter ID etc)

These documents are required as per RBI's guidelines to create your IND linked savings a/c so that you can execute for global fund transfer. The entire process is paperless and can be completed seamlessly.